Australian TGA urges swift attention to ortho implant risk class upgrade
This article was originally published in Clinica
Executive Summary
There is now less than a year for manufacturers of orthopedic implants (hip, knee and shoulder joint replacement implants) selling into the Australian market to observe the Therapeutic Goods Administration’s risk classification upgrade from class IIb (medium-high risk medical devices) to class III (high-risk medical devices).